- Monday, August 24, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global General Anesthesia Drugs Market By Route of Administration (Inhalational and Intravenous), By End-User (Hospitals and Ambulatory Surgery Centers), and By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa)-Global Forecast to 2027.
Global General Anesthesia Drugs Market Overview:
Since 1842, general anesthesia drugs have been widely used in surgery to perform painless operations. The surgeons use general anesthetics drugs to operate on a patient for bringing reversible loss of consciousness. It is essentially a medically induced coma and delivers a patient unresponsive and unconscious. General anesthesia drugs are typically administered intravenously or inhaled. Which unable patients from feeling pain and may cause amnesia. The administration of these drugs can only be done by an anesthesiologist, a specially trained doctor, or a nurse anesthetist. Who will also monitor a patient’s critical signs and rate of breathing during the surgical procedures? Moreover, General anesthesia drugs are safe for most people but can cause short-term side effects among pregnant women, pediatric patients, and geriatric patients.
Global General Anesthesia Drugs Market Insights
The global general anesthesia drugs market is expected to gain a rising CAGR in the forecast period from 2020-2027. The significant factors are the growing demand for general anesthesia drugs during surgical procedures and increasing R&D investments. Additionally, the increasing awareness of chronic diseases and the rising incidence of cancer worldwide will spur the global general anesthesia drugs industry in the future periods. Furthermore, the improving prevalent anesthesia drugs & related system or technology and an increasing number of emergency surgeries to witness general anesthesia drugs’ remarkable growth. The rising clinical usage of available anesthesia drugs in pharmacology, such as the propofol used for cancer treatment, is expected to propel the demand for general anesthesia drugs over the coming years.
Moreover, the upsurge in demand for sedation and anesthetic drugs in heart surgeries, respiratory system-related surgeries, and various cancer surgeries positively impact the general anesthesia drugs market. The increasing number of surgical procedures fuels the demand for the general anesthesia drugs market. Globally the growing geriatric population and increasing healthcare demands in the developing world affects the growth of the general anesthesia drugs market.
Growth Driver
Rising universality of chronic & life-threatening diseases.
Generally, anesthesia is used for primary operations like open-heart surgery, knee replacement surgery, and many surgical procedures to treat cancer and cause patients to lose consciousness. Much general anesthesia is commonly used for primary operations, such as knee and hip replacements, heart surgeries & many types of surgical procedures to treat cancer. These surgeries are lifesaving and would not be possible without general anesthesia. Moreover, cancer is a leading health problem across the globe. The constant growing incidence of cancer and the increasing adoption rate of cancer treatment techniques such as radiotherapy, chemotherapy, and surgery will boost the growth of the general anesthesia market. However, restrictions are often challenging to achieve. Also, the side effect of general anesthesia in pregnant women, pediatric patients, and geriatric patients is high as they respond differently to adults or young patients.
Route of Administration Segmental Analysis
Based on administration, the global general anesthesia drugs market is segregated into inhalational and intravenous. Furthermore, the inhalational segment is divided into sevoflurane, desflurane, isoflurane, and nitrous oxide. Additionally, the intravenous segment is segregated into propofol, benzodiazepines, ketamine, methohexital sodium, etc. The intravenous drug segment is estimated to witness the highest growth over the analysis timeframe. The intravenous drug administration has several benefits, including low cost of available intravenous anesthesia drugs, rapid onset of drug effect, and more flexibility regarding injection volume & rate of dosing. Also, it doesn’t require expensive machinery for drug administration.
The inhalational drug segment will grow significantly due to its significant advantages such as the rapid onset of action & direct delivery to the disease target site, reduced risk of systemic side effects, and long-term pulmonary efficacy.
End-User Segmental Analysis
Based on the end-user, the global general anesthesia drugs market is segmented into hospitals and ambulatory surgery centers. The hospital & surgical centers segment will dominate the global general anesthesia drugs market by 2027 due to the extensive rise in the number of hospitals & surgical centers using general anesthesia for surgery and the rising heart surgery rate.
The ambulatory surgery centers accounted for the largest share of the general anesthesia drugs market in 2020 due to the increasing senior population and elective surgeries.
Region Segmental Analysis
The global general anesthesia drugs market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa by geography. North America estimated to project considerable growth over 2020-2027. Due to the rising number of surgeries, the presence of leading industry players, and the increasing geriatric population.
The Asia Pacific will capture a substantial share of the general anesthesia drugs market by 2027. It is due to the increasing prevalence of chronic diseases and advancements in anesthesia technology.
Competitor Analysis
Companies such as Baxter International Inc., Pfizer Inc., Fresenius SE & Co. KGaA, Par Pharmaceutical, Abbott Laboratories, Bayer AG, Novartis AG, AstraZeneca plc, F. Hoffmann-La Roche, GlaxoSmithKline plc, Piramal Enterprises Limited, Merck & Co., Inc. and AbbVie are the key players in the global general anesthesia drugs market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global general anesthesia drugs manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to general anesthesia drugs
- Regulatory bodies
- Suppliers
- Retailers
The objective of the Research
- Market modeling starts with identifying/measuring a target market where historical data exists. A Market can also include prediction problems, analyzing customer behavior, economic factor, and identifying new patterns from past events, which helps our client deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s expansion rate, taxes, interest rates, trading regulations, exchange rate, and excise duties that can significantly affect the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who shares similar product preferences or characteristics
- . Globally it helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that they can specifically target.
Market Modelling
By Route of Administration
- Inhalational
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
- Intravenous
- Propofol
- Benzodiazepines
- Ketamine
- Methohexital Sodium
- Others
By End-User
- Hospitals
- Ambulatory Surgery Centers (ASC)
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Global General Anesthesia Drugs Market
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Supply Chain Analysis
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Technological Landscape
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Global General Anesthesia Drugs Market Overview
- Market Size & Forecast,2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Market Share & Forecast, 2016-2027
- By Route of Administration
- Inhalational
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
- Intravenous
- Propofol
- Benzodiazepines
- Ketamine
- Methohexital Sodium
- Others
- By End-user
- Hospitals
- Ambulatory Surgery Centers (ASC)
- By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- Inhalational
- By Route of Administration
- Market Size & Forecast,2016-2027
- North America General Anesthesia Drugs Market Overview
- North America General Anesthesia Drugs Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- North America General Anesthesia Drugs Market Share & Forecast,2016-2027
- By Route of Administration
- Inhalational
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
- Intravenous
- Propofol
- Benzodiazepines
- Ketamine
- Methohexital Sodium
- Others
- By End-user
- Hospitals
- Ambulatory Surgery Centers (ASC)
- By Country
- US
- Canada
- Mexico
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on North America General Anesthesia Drugs Market
- Inhalational
- By Route of Administration
- North America General Anesthesia Drugs Market Size & Forecast, 2016-2027
- Europe General Anesthesia Drugs Market Overview
- Europe General Anesthesia Drugs Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Europe General Anesthesia Drugs Market Share & Forecast,2016-2027
- By Route of Administration
- Inhalational
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
- Intravenous
- Propofol
- Benzodiazepines
- Ketamine
- Methohexital Sodium
- Others
- By End-user
- Hospitals
- Ambulatory Surgery Centers (ASC)
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe General Anesthesia Drugs Market
- Inhalational
- By Route of Administration
- Europe General Anesthesia Drugs Market Size & Forecast, 2016-2027
- Asia Pacific General Anesthesia Drugs Market Overview
- Asia Pacific General Anesthesia Drugs Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Asia Pacific General Anesthesia Drugs Market Share & Forecast, 2016-2027
- By Route of Administration
- Inhalational
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
- Intravenous
- Propofol
- Benzodiazepines
- Ketamine
- Methohexital Sodium
- Others
- By End-user
- Hospitals
- Ambulatory Surgery Centers (ASC)
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Asia Pacific General Anesthesia Drugs Market
- Inhalational
- By Route of Administration
- Asia Pacific General Anesthesia Drugs Market Size & Forecast, 2016-2027
- South America General Anesthesia Drugs Market Overview
- South America General Anesthesia Drugs Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- South America General Anesthesia Drugs Market Share & Forecast,2016-2027
- By Route of Administration
- Inhalational
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
- Intravenous
- Propofol
- Benzodiazepines
- Ketamine
- Methohexital Sodium
- Others
- By End-user
- Hospitals
- Ambulatory Surgery Centers (ASC)
- By Country
- Brazil
- Argentina
- Rest of South America
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on South America General Anesthesia Drugs Market
- Inhalational
- By Route of Administration
- South America General Anesthesia Drugs Market Size & Forecast, 2016-2027
- The Middle East & Africa General Anesthesia Drugs Market Overview
- The Middle East & Africa General Anesthesia Drugs Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- The Middle East & Africa General Anesthesia Drugs Market Share & Forecast, 2016-2027
- By Route of Administration
- Inhalational
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
- Intravenous
- Propofol
- Benzodiazepines
- Ketamine
- Methohexital Sodium
- Others
- By End-user
- Hospitals
- Ambulatory Surgery Centers (ASC)
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of the Middle East & Africa
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on the Middle East & Africa General Anesthesia Drugs Market
- Inhalational
- By Route of Administration
- The Middle East & Africa General Anesthesia Drugs Market Size & Forecast, 2016-2027
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- Baxter International Inc.
- Pfizer Inc.
- Fresenius SE & Co. KGaA
- Par Pharmaceutical
- Abbott Laboratories
- Bayer AG
- Novartis AG
- Astra Zeneca plc
- Hoffmann-La Roche
- Glaxo Smith Kline plc
- Piramal Enterprises Limited
- Merck & Co., Inc.
- Other Prominent Players
